MAPK1 and muscular atrophy: Zheng et al. (2010) showed in L6 cells that active form of FOXO3a increases IRS‐2 in the skeletal muscle, inducing greater MEK/ERK pathway and Sp1 activation and consequent activation of ubiquitin (UbC), leading to muscular atrophy.